Bortezomib in the Treatment of Multiple Myeloma
Multiple Myeloma (MM) is the second most common type of blood cancer, resulting from an overproduction of cancerous infection-fighting white blood cells, known as plasma cells. Plasma cells are a crucial part of the immune system responsible for the production of antibodies. Bortezomib is a promisin...
Clasificación: | Libro Electrónico |
---|---|
Autor Corporativo: | |
Otros Autores: | , , |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
Basel :
Springer Basel : Imprint: Springer,
2011.
|
Edición: | 1st ed. 2011. |
Colección: | Milestones in Drug Therapy,
|
Temas: | |
Acceso en línea: | Texto Completo |